$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[국내논문] 비기환, 대칠기탕 및 목향빈랑환 열수 추출물에 의한 인간 간세포암종 HepG2 세포의 세포사멸 유도에 미치는 자가포식의 역할
The Role of Autophagy on the Induction of Apoptosis by Water Extracts of Bigihwan, Daechilgitang and Mokwhyangbinranghwan in HepG2 Human Hepatocellular Carcinoma Cells 원문보기

大韓韓醫學方劑學會誌 = Herbal formula science, v.30 no.2, 2022년, pp.67 - 83  

박상은 (동의대학교 한의과대학 간계내과학교실) ,  홍수현 (동의대학교 한의과대학 생화학교실) ,  최영현 (동의대학교 한의과대학 생화학교실)

Abstract AI-Helper 아이콘AI-Helper

Objectives : In this study, the anticancer activity of water extracts of three herbal medicine formulas, Bigihwan (BGH), Daechilgitang (DCGT) and Mokwhyangbinranghwan (MHBRH) listed in Donguibogam, was evaluated in HepG2 cells, a human hepatocellular carcinoma cell line. Methods : We investigated wh...

주제어

표/그림 (8)

참고문헌 (40)

  1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209-49. 

  2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394-424. 

  3. Ikeda M, Morizane C, Ueno M, Okusaka T, Ishii H, Furuse J. Chemotherapy for hepatocellular carcinoma: Current status and future perspectives. Jpn J Clin Oncol. 2018;48:103-14. 

  4. Yang JD, Heimbach JK. New advances in the diagnosis and management of hepatocellular carcinoma. BMJ. 2020;371:m3544. 

  5. Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019;380:1450-62. 

  6. Grandhi MS, Kim AK, Ronnekleiv-Kelly SM, Kamel IR, Ghasebeh MA, Pawlik TM. Hepatocellular carcinoma: From diagnosis to treatment. Surg Oncol. 2016;25:74-85. 

  7. Garcia-Pras E, Fernandez-Iglesias A, Gracia-Sancho J, Perez-Del-Pulgar S. Cell death in hepatocellular carcinoma: Pathogenesis and therapeutic opportunities. Cancers (Basel). 2021;14:48. 

  8. Chen J, Wang X, Xia T, Bi Y, Liu B, Fu J, Zhu R. Molecular mechanisms and therapeutic implications of dihydromyricetin in liver disease. Biomed Pharmacother. 2021;142:111927. 

  9. Allaire M, Rautou PE, Codogno P, Lotersztajn S. Autophagy in liver diseases: Time for translation? J Hepatol. 2019;70:985-98. 

  10. Sun EJ, Wankell M, Palamuthusingam P, McFarlane C, Hebbard L. Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma. Biomedicines. 2021;9:1639. 

  11. Guicciardi ME, Gores GJ. Apoptosis: A mechanism of acute and chronic liver injury. Gut. 2005;54:1024-33. 

  12. Hu B, An HM, Wang SS, Chen JJ, Xu L. Preventive and therapeutic effects of Chinese herbal compounds against hepatocellular carcinoma. Molecules. 2016;21:142. 

  13. Kim SY, Hong SH, Choi SH, Cheong J, Choi YH. The anti-cancer effects of Bigihwan, Daechilgithang, and Mokwhyangbinranghwan ethanol extracts in human hepatocellular carcinoma cells. J Life Sci. 2020;30:460-67. 

  14. Kim MY, Lee H, Hong SH, Park C, Choi YH. Comparison of anti-cancer potentials of water extracts of Bigihwan, Daechilgithang and Mokwhyangbinranghwan in human hepatocellular carcinoma cells. Herbal Formula Sci. 2020;28: 15-27. 

  15. Qiu GH, Xie X, Xu F, Shi X, Wang Y, Deng L. Distinctive pharmacological differences between liver cancer cell lines HepG2 and Hep3B. Cytotechnology. 2015;67:1-12. 

  16. Yu MH, Tsai MC, Wang CC, Wu SW, Chang YJ, Wu CH, Wang CJ. Mulberry leaf polyphenol extract and rutin induces autophagy regulated by p53 in human hepatoma HepG2 cells. Pharmaceuticals (Basel). 2021;14:1310. 

  17. Kim SM, Ha SE, Lee HJ, Rampogu S, Vetrivel P, Kim HH, Venkatarame Gowda Saralamma V, Lee KW, Kim GS. Sinensetin induces autophagic cell death through p53-related AMPK/mTOR signaling in hepatocellular carcinoma HepG2 cells. Nutrients. 2020;12:2462. 

  18. Cheng KC, Wang CJ, Chang YC, Hung TW, Lai CJ, Kuo CW, Huang HP. Mulberry fruits extracts induce apoptosis and autophagy of liver cancer cell and prevent hepatocarcinogenesis in vivo. J Food Drug Anal. 2020;28:84-93. 

  19. Lee Y, Kwon YH. Regulation of apoptosis and autophagy by luteolin in human hepatocellular cancer Hep3B cells. Biochem Biophys Res Commun. 2019;517:617-22. 

  20. Lalier L, Vallette F, Manon S. Bcl-2 family members and the mitochondrial import machineries: The roads to death. Biomolecules. 2022;12:162. 

  21. Glab JA, Cao Z, Puthalakath H. Bcl-2 family proteins, beyond the veil. Int Rev Cell Mol Biol. 2020;351:1-22. 

  22. Guerra-Castellano A, Marquez I, Perez-Mejias G, Diaz-Quintana A, De la Rosa MA, Diaz-Moreno I. Post-translational modifications of cytochrome c in cell life and disease. Int J Mol Sci. 2020;21:8483. 

  23. Burke PJ. Mitochondria, bioenergetics and apoptosis in cancer. Trends Cancer. 2017;3:857-70. 

  24. Bock FJ, Tait SWG. Mitochondria as multifaceted regulators of cell death. Nat Rev Mol Cell Biol. 2020;21:85-100. 

  25. Kalpage HA, Bazylianska V, Recanati MA, Fite A, Liu J, Wan J, Mantena N, Malek MH, Podgorski I, Heath EI, Vaishnav A, Edwards BF, Grossman LI, Sanderson TH, Lee I, Huttemann M. Tissue-specific regulation of cytochrome c by post-translational modifications: Respiration, the mitochondrial membrane potential, ROS, and apoptosis. FASEB J. 2019;33:1540-53. 

  26. Boice A, Bouchier-Hayes L. Targeting apoptotic caspases in cancer. Biochim Biophys Acta Mol Cell Res. 2020;1867:118688. 

  27. Ugarte-Uribe B, Garcia-Saez AJ. Apoptotic foci at mitochondria: in and around Bax pores. Philos Trans R Soc Lond B Biol Sci. 2017;372:20160217. 

  28. Dadsena S, King LE, Garcia-Saez AJ. Apoptosis regulation at the mitochondria membrane level. Biochim Biophys Acta Biomembr. 2021;1863: 183716. 

  29. Henning RJ, Bourgeois M, Harbison RD. Poly(ADP-ribose) polymerase (PARP) and PARP inhibitors: Mechanisms of action and role in cardiovascular disorders. Cardiovasc Toxicol. 2018;18:493-506. 

  30. Chmurska A, Matczak K, Marczak A. Two faces of autophagy in the struggle against cancer. Int J Mol Sci. 2021;22:2981. 

  31. Thorburn A. Crosstalk between autophagy and apoptosis: Mechanisms and therapeutic implications. Prog Mol Biol Transl Sci. 2020;172:55-65. 

  32. Yang J, Sun Y, Xu F, Liu W, Hayashi T, Mizuno K, Hattori S, Fujisaki H, Ikejima T. Autophagy and glycolysis independently attenuate silibinin-induced apoptosis in human hepatocarcinoma HepG2 and Hep3B cells. Hum Exp Toxicol. 2021;40:2048-62. 

  33. Lou LL, Cheng ZY, Guo R, Yao GD, Song SJ. Alkaloids from Juglans mandshurica maxim induce distinctive cell death in hepatocellular carcinoma cells. Nat Prod Res. 2019;33:911-4. 

  34. Condello M, Pellegrini E, Caraglia M, Meschini S. Targeting autophagy to overcome human diseases. Int J Mol Sci. 2019;20:725. 

  35. Urbanska K, Orzechowski A. The secrets of alternative autophagy. Cells. 2021;10:3241. 

  36. Fan X, Huang T, Tong Y, Fan Z, Yang Z, Yang D, Mao X, Yang M. p62 works as a hub modulation in the ageing process. Ageing Res Rev. 2022;73:101538. 

  37. Islam MA, Sooro MA, Zhang P. Autophagic regulation of p62 is critical for cancer therapy. Int J Mol Sci. 2018;19:1405. 

  38. Yang W, Su J, Li M, Li T, Wang X, Zhao M, Hu X. Myricetin induces autophagy and cell cycle arrest of HCC by inhibiting MARCH1-regulated Stat3 and p38 MAPK signaling pathways. Front Pharmacol. 2021;12:709526. 

  39. Xie L, Li M, Liu D, Wang X, Wang P, Dai H, Yang W, Liu W, Hu X, Zhao M. Secalonic acid-F, a novel mycotoxin, represses the progression of hepatocellular carcinoma via MARCH1 regulation of the PI3K/AKT/β-catenin signaling pathway. Molecules. 2019;24:393. 

  40. Zheng Y, Zhang W, Xu L, Zhou H, Yuan M, Xu H. Recent progress in understanding the action of natural compounds at novel therapeutic drug targets for the treatment of liver cancer. Front Oncol. 2022;11:795548. 

저자의 다른 논문 :

관련 콘텐츠

오픈액세스(OA) 유형

FREE

Free Access. 출판사/학술단체 등이 허락한 무료 공개 사이트를 통해 자유로운 이용이 가능한 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로